Is the public enough aware to accept a vaccination program against human papillomavirus? [2]

Vaccine

Volumn 23, Issue 25, 2005, Pages 3231-

  Tjalma, W A A ^a   Damme, P Van ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

CANCER INCIDENCE; HEPATITIS B; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; VACCINATION; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

EID: 17144431945     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.143     Document Type: Letter

References (6)

1. W.A. Tjalma, M. Arbyn, J. Paavonen, T.R. van Waes, and J.J. Bogers Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer Int J Gynecol Cancer 14 2004 751 761
2. S.R. Pagliusi, and M.T. Aguado Efficacy and other milestones for human papillomavirus vaccine introduction Vaccine 23 2004 569 578
3. D.M. Harper, E.L. Franco, C. Wheeler, D.G. Ferris, D. Jenkins, and A. Schuind Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial Lancet 364 2004 1757 1765
4. J. Waller, K. McCaffery, S. Forrest, A. Szarewski, L. Cadman, and J. Wardle Awareness of human papillomavirus among women attending a well woman clinic Sex Transm Infect 79 2003 320 322
5. J. Waller, K. McCaffery, and J. Wardle Beliefs about the risk factors for cervical cancer in a British population sample Prev Med 38 2004 745 753
6. E. Lazcano-Ponce, L. Rivera, E. Arillo-Santillan, J. Salmeron, M. Hernandez-Avila, and N. Munoz Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico Arch Med Res 32 2001 243 247